Company Filing History:
Years Active: 2018
Title: Innovator Profile: Peter Kettenmann
Introduction
Peter Kettenmann is a noteworthy inventor based in Waghaeusel, Germany. He has made significant contributions in the field of drug infusion systems, particularly through his innovative patent.
Latest Patents
Kettenmann holds a patent for "Initialization of a dosing unit for drug infusion." This patent describes a method for initializing a dosing unit of an ambulatory infusion system, which is crucial for administering medications effectively. The method involves a series of steps, including providing a dosing chamber with a minimal volume, closing a draining valve while keeping a filling valve open, and measuring initial reservoir fluid pressure. Furthermore, it outlines how to increase the dosing chamber volume to ensure proper function, ultimately leading to a reliable drug infusion experience.
Career Highlights
Peter Kettenmann currently works at Roche Diabetes Care, Inc., where he applies his expertise to advance medical technology. His work in this respected company highlights his commitment to improving patient care and the effectiveness of drug delivery systems.
Collaborations
Throughout his career, Kettenmann has collaborated with fellow professionals, including co-worker David Teutsch. Such partnerships are vital in driving innovation and ensuring that complex medical challenges are addressed effectively.
Conclusion
Peter Kettenmann is a prominent figure in the realm of medical innovations, especially in drug infusion technologies. His patent signifies a leap forward in enhancing the usability and efficiency of ambulatory infusion systems. As he continues his work at Roche Diabetes Care, inc., the medical community eagerly anticipates further developments arising from his innovative spirit.